News, views and contacts from the global Drugdevelopment industry

Today on Drug Development Technology

Baricitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis

Baricitinib is the first once-daily oral selective JAK1 and JAK2 inhibitor for the treatment of moderate to severe active rheumatoid...

Eliquis (apixaban) for Prevention of Stroke in Nonvalvular Atrial Fibrillation (NVAF) Patients

Eliquis (apixaban) is an anticoagulant drug that was jointly developed by Bristol-Myers Squibb and Pfizer.

Darzalex (daratumumab) for the Treatment of Multiple Myeloma

Darzalex (daratumumab) is the world's first human anti-CD38 monoclonal antibody (mAb) approved for the treatment of patients with...

Kanuma (sebelipase alfa) for the Treatment of Lysosomal Acid Lipase Deficiency (LAL-D)

Kanuma™ (sebelipase alfa) is an enzyme replacement therapy (ERT) for the treatment of patients of all ages with lysosomal acid lipase...


Latest Products & Services

Malvern Instruments
Malvern Viscosizer TD with...
Malvern Viscosizer TD uses Taylor dispersion analysis for automated biophysical...
See all products

Latest Features

Pharma Technology Focus – Issue 43
21 January, 2016 In this issue: A look inside China’s pharmaceutical market, GSK’s pipeline to 2020, tackling the world’s most pressing clinical needs, new digital tools for clinical trials, a new approach...
See all features

cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115